BioSpace News Archive

Press Releases

Belantamab Mafodotin shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse

December 10, 2024
·
12 min read
Press Releases

Ascendia Pharmaceutical Solutions Launched to Meet Drug Development and Manufacturing Needs

December 10, 2024
·
2 min read
Press Releases

Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - December 9, 2024

December 10, 2024
·
2 min read
Press Releases

Krystal Biotech Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa

December 10, 2024
·
3 min read
Press Releases

Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium

December 10, 2024
·
6 min read
Press Releases

Fate Therapeutics Presents New Phase 1 Clinical Data of FT819 Off-the-shelf, CAR T-cell Product Candidate for Systemic Lupus Erythematosus

December 10, 2024
·
11 min read
Press Releases

Roche commences tender offer for all shares of Poseida Therapeutics, Inc. for $9.00 per share in cash, plus a non-tradeable contingent value right for up to $4.00 per share in cash

December 10, 2024
·
8 min read
Press Releases

Daré Bioscience Announces Publication in Sexual Medicine of Positive Findings from Demographic, Behavioral and Medication Use Subgroup Analyses in the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%

December 10, 2024
·
11 min read
Press Releases

aTyr Pharma Announces Third Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis

December 10, 2024
·
5 min read
Press Releases

Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)

December 10, 2024
·
5 min read